Evaluate ADCT stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in ADCT? | Glauxie AI

Q: What are the risks of investing in ADCT?

ADC Therapeutics S.A. (ADCT) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Ameet Mallik. ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product... Employees: 32,000.

Q: How much debt does ADCT have?

Review ADCT total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is ADCT a good long-term investment?

Evaluate ADCT as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in ADCT?

🦉

ADC Therapeutics S.A. (ADCT)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOAmeet Mallik

ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large...

Key Executives

Name	Title
Ameet Mallik	Chief Executive Officer & Director
David S. Ege	Chief Technical Officer
Jose I. Carmona	Chief Financial Officer
Kimberly Pope	Senior Vice President & Chief People Officer
Kristen Harrington-Smith	Chief Commercial Officer
Lisa Michelle Kallebo	Corporate Controller & Chief Accounting Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ADCT Profile Financials

Is ADCT stock safe? How much debt does ADCT have? Is ADCT a good long-term investment?